Magnesium intake by enteral formulation affects serum magnesium concentration in patients undergoing hemodialysis

Ther Apher Dial. 2022 Aug;26(4):749-755. doi: 10.1111/1744-9987.13760. Epub 2021 Dec 2.

Abstract

Decreased serum magnesium levels are associated with mortality and fractures in patients with chronic kidney disease; however, there is no recommendation for Mg intake in these populations. This study used cross-sectional analysis to examine the association between Mg intake and serum Mg levels in patients undergoing hemodialysis. Sixty-one patients were included. The daily Mg intake was 185 mg (IQR: 151-203 mg), and serum Mg level was 2.4 mg/dL (IQR: 2.2-2.7 mg/dL). Multiple regression analysis showed that intake of enteral formulation by tube feeding was an independent factor associated with serum Mg level (B = 0.90 [95% confidence interval: 0.61-1.20], p < 0.01). These findings may aid in serum Mg level management through diet and enteral formulation in patients undergoing hemodialysis.

Keywords: enteral formulation; hemodialysis; magnesium; tube feeding.

MeSH terms

  • Cross-Sectional Studies
  • Diet
  • Humans
  • Magnesium*
  • Renal Dialysis
  • Renal Insufficiency, Chronic* / therapy

Substances

  • Magnesium